A comparative study on clinical efficacy of various modalities of localized therapy in chronic plaque psoriasis
Not Applicable
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2020/03/024068
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of more than 18 years of age attending the Dermatology OPD during the study period with stable plaque psoriasis for 6 months, involving 10%of body surface area and minimal PASI of 10 at screening will be included.
Patient who has not undergone any prior systemic or topical treatment.
Those who are giving consent to participate in the study.
Those who are willing for follow up.
Exclusion Criteria
Patients who received any other treatments for their psoriasis before enrolment,renal,liver impairment, pregnancy, fever,infection, pustular psoriasis & immunosuppressed.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the clinical efficacy of treatment for chronic plaque psoriasisTimepoint: 4-6 months
- Secondary Outcome Measures
Name Time Method To identify the better treatment regimen for chronic plaque psoriasis. <br/ ><br>To identify the side effects and recurrence rate following treatmentTimepoint: 4-6 months